MEDICINOVA, INC. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
MEDICINOVA, INC. (MNOV) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $77.32 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-10-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2017-10-23
- MEDICINOVA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2017-09-30 was $12.29K, a 67.48% decline year-over-year.
- MEDICINOVA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2017-06-30 was $0.00.
- MEDICINOVA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2017-03-31 was $65.03K, a 30.25% increase year-over-year.
- MEDICINOVA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2016-09-30 was $37.81K.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 month |
|---|---|---|---|
| 2017-09-30 | $12.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | $12.29K derived: sum of 2 quarters · filed 2017-10-23 | $77.32K 10-Q · filed 2017-10-23 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $65.03K 10-Q · filed 2017-07-26 | |
| 2017-03-31 | $65.03K 10-Q · filed 2017-04-26 | ||
| 2016-09-30 | $37.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | $37.81K derived: sum of 2 quarters · filed 2017-10-23 | $87.73K 10-Q · filed 2017-10-23 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $49.92K 10-Q · filed 2017-07-26 | |
| 2016-03-31 | $49.92K 10-Q · filed 2017-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |